Publikationen

2022

• Disruption of amphetamine sensitization by alteration of dendritic thin spines in the nucleus accumbens core.
  Cai WT, Kim WY, Kwak MJ, Rim H, Lee SE, Riecken LB, Morrison H, Kim JH
  J Neurochem 2022, 161(3), 266-80
  
• Planning preclinical confirmatory multicenter trials to strengthen translation from basic to clinical research – a multi-stakeholder workshop report
  Drude NI, Martinez-Gamboa L, Danziger M, Collazo A, Kniffert S, Wiebach J, Nilsonne G, Konietschke F, Piper SK, Pawel S, Micheloud C, Held L, Frommlet F, Segelcke D, Pogatzki-Zahn EM, Voelkl B, Friede T, Brunner E, Dempfle A, Haller B, Jung MJ, Riecken LB, Kuhn HG, Tenbusch M, Serna Higuita LM, Remarque EJ, Grüninger-Egli SL, Manske K, Kobold S, Rivalan M, Wedekind L, Wilcke JC, Boulesteix AL, Meinhardt MW, Spanagel R, Hettmer S, von Lüttichau I, Regina C, Dirnagl U, Toelch U
  Translational Medicine Communications 2022, 7(24), doi 10.1186/s41231-022-00130-8
  
• CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
  Gerardo-Ramírez M, Keggenhoff FL, Giam V, Becker D, Groth M, Hartmann N, Straub BK, Morrison H, Galle PR, Marquardt JU, Herrlich P, Hartmann M
  Int J Mol Sci 2022, 23(15), 8616
  
• The tumor suppressor protein merlin regulates myelin phagocytosis in Schwann cells and macrophages
  Helbing D
  Dissertation 2022, Jena, Germany
  
• A Ponceau S Staining-Based Dot Blot Assay for Rapid Protein Quantification of Biological Samples.
  Helbing* DL, Böhm* L, Oraha N, Stabenow LK, Cui Y
  Gels 2022, 8(1), 43 * equal contribution
  
• Role of CD44 in metastasis formation of spontaneous osteosarcoma of Nf2-deficient mice
  Ma J
  Dissertation 2022, Jena, Germany
  
• Ezrin deficiency triggers glial fibrillary acidic protein upregulation and a distinct reactive astrocyte phenotype.
  Schacke S, Kirkpatrick J, Stocksdale A, Bauer R, Hagel C, Riecken LB, Morrison H
  Glia 2022, 70(12), 2309-29
  
• Oxidative Glucose Metabolism Promotes Senescence in Vascular Endothelial Cells.
  Stabenow LK, Zibrova D, Ender C, Helbing DL, Spengler K, Marx C, Wang ZQ, Heller R
  Cells 2022, 11(14), 2213
  

2021

• Merlin dependent intra- and intercellular signaling network alterations in NF2 disease
  Carlstedt A
  Dissertation 2021, Jena, Germany
  
• Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
  Chang LS, Oblinger JL, Smith AE, Ferrer M, Angus SP, Hawley E, Petrilli AM, Beauchamp RL, Riecken LB, Erdin S, Poi M, Huang J, Bessler WK, Zhang X, Guha R, Thomas C, Burns SS, Gilbert TSK, Jiang L, Li X, Lu Q, Yuan J, He Y, Dixon SAH, Masters A, Jones DR, Yates CW, Haggarty SJ, La Rosa S, Welling DB, Stemmer-Rachamimov AO, Plotkin SR, Gusella JF, Guinney J, Morrison H, Ramesh V, Fernandez-Valle C, Johnson GL, Blakeley JO, Clapp DW, Synodos for NF2 Consortium
  PLoS One 2021, 16(7), e0252048